The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study. Issue 8 (3rd July 2021) - Martínez-López, Joaquín; Mustjoki, Satu; Porkka, Kimmo; Klisovic, Rebecca B.; Wolf, Dominik; Busque, Lambert; Hernández-Boluda, Juan Carlos; Swanink, Rene; Martin Regueira, Patricia; Lipton, Jeffrey H.